Our partner in Lebanon

This timeline allows you to explore a timeline highlighting some of the EU4Monitoring Drugs (EU4MD) project's achievements. As part of its ongoing commitment to strengthening cooperation and sharing expertise, EMCDDA developed the EU4Monitoring Drugs (EU4MD) project, funded by the European Union....

This report presents an analysis of the drug markets in the European Neighbourhood Policy-South region covering Algeria, Egypt, Israel, Jordan, Lebanon, Libya, Morocco, Palestine (*), Syria and Tunisia. Focused on providing insights into drug production, trafficking, sale, use and harms, the report...

The European Web Survey on Drugs collected data during March and May 2021 from people who use drugs, are aged 18 or older, and live in 21 EU and 9 non-EU countries including Lebanon. In this period, the populations in many European and neighbouring countries were experiencing COVID-19-related...

Between March and May 2021, the EU4Monitoring Drugs (EU4MD) project supported the mapping of national prevention systems in European Neighbourhood Policy (ENP) area countries. This briefing describes the rationale and methodology of the prevention system mapping, presenting selected findings and...

This tool lets you examine and compare the penalties or rehabilitative responses for the core offences of drug use, possession for personal use, and supply-related offences, across countries in Europe. It also allows you to see how the laws vary those penalties according to the type or quantity of...

Since the beginning of 2020, the world has been experiencing an unprecedented public health emergency caused by the coronavirus disease (COVID-19) pandemic, which has led to progressive introduction of social distancing and other control measures by national governments. To investigate the effects...